Published in Cancer on December 01, 2008
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
The sentinel node in breast cancer--a multicenter validation study. N Engl J Med (1998) 8.48
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol (1993) 4.22
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer (1999) 1.48
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg (2005) 1.39
A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg (2007) 1.24
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer (2001) 1.19
Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg (2005) 1.18
The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol (2005) 1.18
Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol (2007) 1.14
Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg (2001) 0.97
Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg (2007) 0.93
Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery--a prospective study. Eur J Cancer (2006) 0.93
Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients--results of a large series. J Surg Oncol (2004) 0.91
Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery (1999) 0.90
Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg (2002) 0.86
Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Am J Surg (2006) 0.84
The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Cytopathology (2005) 0.83
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA (2011) 16.68
Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol (2002) 6.51
MAKER: an easy-to-use annotation pipeline designed for emerging model organism genomes. Genome Res (2007) 6.48
Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol (2005) 3.65
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol (2005) 3.50
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Local therapy and survival in breast cancer. N Engl J Med (2007) 3.33
Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol (2003) 3.27
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol (2002) 3.25
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol (2011) 3.22
SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Res (2007) 3.02
Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med (2014) 2.89
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol (2011) 2.87
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am (2003) 2.82
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med (2013) 2.76
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol (2007) 2.50
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol (2009) 2.40
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst (2004) 2.37
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA (2011) 2.28
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov (2012) 2.23
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.21
Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst (2009) 2.18
Management of the clinically node-negative axilla: what have we learned from the clinical trials? Oncology (Williston Park) (2014) 2.17
Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy. Ann Surg Oncol (2005) 2.13
Does aggressive local therapy improve survival in metastatic breast cancer? Surgery (2002) 2.13
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst (2005) 2.10
Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) (2011) 2.09
Correlates of between-surgeon variation in breast cancer treatments. Med Care (2006) 2.08
Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice? Am J Clin Pathol (2012) 1.99
Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer (2009) 1.99
Beauty and the beast: management of breast cancer after plastic surgery. Ann Surg (2008) 1.98
The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Arch Pathol Lab Med (2014) 1.98
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer (2008) 1.98
Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol (2009) 1.96
Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J (2010) 1.90
An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns (2006) 1.87
Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol (2007) 1.84
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol (2013) 1.84
Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer (2004) 1.82
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prev Res (Phila) (2010) 1.80
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform (2007) 1.76
High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J (2006) 1.76
Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys (2008) 1.74
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys (2007) 1.71
De novo assembly and validation of planaria transcriptome by massive parallel sequencing and shotgun proteomics. Genome Res (2011) 1.70
Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol (2010) 1.69
Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res (2005) 1.67
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res (2011) 1.65
Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) (2007) 1.58
Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. J Clin Oncol (2009) 1.56
Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer (2007) 1.54
Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer. Cancer (2008) 1.54
Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol (2005) 1.53
Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg (2011) 1.53
Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol (2010) 1.52
What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol (2009) 1.52
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clin Cancer Res (2012) 1.50
Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type. Breast J (2015) 1.48
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer (2010) 1.47
Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns (2006) 1.46
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol (2012) 1.45
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen. Cancer (2006) 1.45
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol (2006) 1.41
Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg (2013) 1.40
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg (2005) 1.39
Locoregional strategies for colorectal hepatic metastases. Clin Colorectal Cancer (2003) 1.39
Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol (2009) 1.33
Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer (2003) 1.33
Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol (2007) 1.31
Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys (2008) 1.30
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29
Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res (2011) 1.29
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol (2002) 1.24
Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma. Changes in management and determinants of where care is delivered. Cancer (2002) 1.22
Double-balloon enteroscopy in the elderly: safety, findings, and diagnostic and therapeutic success. Gastrointest Endosc (2010) 1.21
Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol (2011) 1.21
Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA (2013) 1.20
Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision? Ann Surg Oncol (2011) 1.20
Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol (2012) 1.19
Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer. Med Care (2010) 1.18
The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol (2014) 1.18
Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol (2013) 1.17
Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care (2010) 1.16